Foghorn Therapeutics Inc.
General ticker "FHTX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $409.8M
Foghorn Therapeutics Inc. follows the US Stock Market performance with the rate: 44.6%.
Estimated limits based on current volatility of 4.4%: low 4.81$, high 5.25$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.42$, 8.61$]
- 2024-12-30 to 2025-12-30 estimated range: [4.34$, 10.22$]
Financial Metrics affecting the FHTX estimates:
- Negative: Non-GAAP EPS, $ of -2.34 <= 0.10
- Negative: Operating profit margin, % of -75.96 <= 1.03
- Negative: Operating cash flow per share per price, % of -35.24 <= 2.35
- Negative: negative Net income
- Negative: Industry earnings per price (median), % of -26.04 <= 1.31
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term FHTX quotes
Long-term FHTX plot with estimates
Financial data
YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|
Operating Revenue | $1.32MM | $19.23MM | $34.16MM |
Operating Expenses | $102.05MM | $136.37MM | $142.06MM |
Operating Income | $-100.73MM | $-117.14MM | $-107.91MM |
Non-Operating Income | $-0.59MM | $8.26MM | $13.71MM |
Interest Expense | $1.91MM | $0.00MM | $0.00MM |
R&D Expense | $80.33MM | $105.62MM | $109.69MM |
Income(Loss) | $-101.32MM | $-108.88MM | $-94.20MM |
Taxes | $0.00MM | $0.00MM | $4.23MM |
Profit(Loss) | $-101.32MM | $-108.88MM | $-98.43MM |
Stockholders Equity | $96.87MM | $0.11MM | $-77.19MM |
Assets | $519.77MM | $404.88MM | $285.92MM |
Operating Cash Flow | $-50.25MM | $193.61MM | $-118.11MM |
Capital expenditure | $3.31MM | $1.21MM | $1.22MM |
Investing Cash Flow | $36.17MM | $-244.32MM | $144.45MM |
Financing Cash Flow | $22.42MM | $1.76MM | $1.78MM |
Earnings Per Share* | $-2.78 | $-2.62 | $-2.34 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.